Imodium (Loperamide Hydrochloride)

Loperamide acts as an agonist at peripheral µ‑opioid receptors in the gastrointestinal tract. Activation of these receptors decreases peristalsis, prolongs transit time, and enhances absorption of water and electrolytes, which collectively reduces the volume and frequency of stools.

The appropriate dose of Imodium is determined by a qualified healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount without medical advice.

Safety data for loperamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare provider.

To order Imodium, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to Imodium is diphenoxylate/atropine. Both reduce intestinal motility, but loperamide has minimal central nervous system penetration, resulting in fewer opioid‑related side effects. Diphenoxylate/atropine includes an anticholinergic component, which can cause additional dry‑mouth and blurred‑vision effects.

Imodium should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Imodium is taken orally. Tablets should be swallowed whole with a glass of water. It can be taken with or without food, but patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include severe constipation leading to bowel obstruction, toxic megacolon, and cardiac arrhythmias such as QT prolongation, especially when loperamide levels become elevated. Patients should seek immediate medical attention if they experience abdominal pain, vomiting, or irregular heartbeats.

Imodium should not be used by children under two years of age, individuals with known hypersensitivity to loperamide, or patients with bacterial enterocolitis, pseudomembranous colitis, or acute dysentery. Caution is also advised for those with severe hepatic impairment.